Single judge converted ex parte ad-interim reliefs granted on 03.01.2022 and 03.02.2022 into absolute reliefs in a trade mark/passing off suit, noting the absence of the defendants and the plaintiff's strong prima facie case.
Ad-interim reliefs granted on 03.01.2022 and 03.02.2022 were made absolute.
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
25_IAL30034_21.doc
COMMERCIAL IP SUIT NO.32 OF 2022
Sun Pharma Laboratories Limited … Applicant In the matter between: Sun Pharma Laboratories Limited … Plaintiff Vs. Suraksha Pharma Private Limited and another … Defendants
WITH
C.R.R.NO.35 OF 2022
IN COMMERCIAL IP SUIT NO.32 OF 2022
Mr. Ashutosh Kane a/w. Mr. Kanishk Agarwal i/b. W. S. Kane & Co. for Plaintiff.
Ms. Rekha Rane, 2nd Assistant to Court Receiver.
CORAM : MANISH PITALE, J. DATE : OCTOBER 10, 2022
P.C. :
In this application, on 03.01.2022, this Court had granted the exparte ad-interim reliefs in favour of the plaintiff.
1/2
25_IAL30034_21.doc
(MANISH PITALE, J.)
Minal Parab
2/2
1 issue framed by the court
Whether the ex parte ad-interim reliefs granted in the underlying commercial IP suit should be made absolute in the absence of the defendants.
Sun Pharma Laboratories Limited
Suraksha Pharma Private Limited
Manish Pitale
As recorded by the court registry
Judgements on the same questions, provisions and authorities, from every court
